Abivax (ABVX) Interest & Investment Income (2024 - 2026)

Abivax's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $14.9 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 815.0% year-over-year to $14.9 million; the TTM figure through Mar 2026 stood at $48.3 million (up 262.41% YoY), while the FY2025 annual figure was $32.1 million, up 118.51% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $14.9 million, up from $5.6 million in the prior quarter.
• The five-year high for Interest & Investment Income was $23.9 million in Q3 2025, with the low at $1.6 million in Q1 2025.
• The 3-year median for Interest & Investment Income is $4.0 million (2024), against an average of $7.6 million.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income sank 75.08% in 2025, then soared 815.0% in 2026.
• Abivax's Interest & Investment Income stood at $4.0 million in 2024, then jumped by 38.27% to $5.6 million in 2025, then surged by 167.23% to $14.9 million in 2026.
• Business Quant data shows ABVX's Interest & Investment Income at $14.9 million in Q1 2026, $5.6 million in Q4 2025, and $23.9 million in Q3 2025.